AAAAAA
Results:
1-13
|
Results: 13
Authors:
Einsele, H
Bertz, H
Beyer, J
Kiehl, MG
Runde, V
Kolb, HJ
Holler, E
Beck, R
Schwerdfeger, R
Schumacher, U
Hebart, H
Martin, H
Kienast, J
Ullmann, AJ
Maschmeyer, G
Kruger, W
Link, H
Schmidt, CA
Oettle, H
Klingebiel, T
Citation: H. Einsele et al., Reports of society meetings and consensus conferences, DEUT MED WO, 126(45), 2001, pp. 1278-1284
Authors:
Maschmeyer, G
Citation: G. Maschmeyer, Pneumonia in febrile neutropenic patients: radiologic diagnosis, CURR OPIN O, 13(4), 2001, pp. 229-235
Authors:
Buchner, T
Hiddemann, W
Berdel, W
Wormann, B
Loffler, H
Schoch, C
Haferlach, T
Ludwig, WD
Maschmeyer, G
Staib, P
Andreesen, R
Balleisen, L
Haase, D
Eimermacher, H
Aul, C
Rasche, H
Uhlig, J
Gruneisen, A
Reis, HE
Hartlapp, J
Hirschmann, WD
Weh, HJ
Pielken, HJ
Gassmann, W
Sauerland, MC
Heinecke, A
Citation: T. Buchner et al., Remission induction therapy: the more intensive the better?, CANC CHEMOT, 48, 2001, pp. S41-S44
Authors:
Reich, G
Mapara, MY
Reichardt, P
Dorken, B
Maschmeyer, G
Citation: G. Reich et al., Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiplemyeloma and patients with solid tumors, BONE MAR TR, 27(5), 2001, pp. 525-529
Authors:
Reich, G
Held, T
Siegert, W
Kampf, D
Dorken, B
Maschmeyer, G
Citation: G. Reich et al., Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation, BONE MAR TR, 27(3), 2001, pp. 341-343
Authors:
Wilhelm, M
Hiddemann, W
Maschmeyer, G
Link, H
Buchheidt, D
Glass, B
Cornely, O
Helmerking, M
Adam, D
Citation: M. Wilhelm et al., Empirical antimicrobial therapy of FUO and proved infections in neutropenic patients, HEMAT BLOOD, 40, 2001, pp. 324-329
Authors:
Maschmeyer, G
Braveny, I
Citation: G. Maschmeyer et I. Braveny, Review of the incidence and prognosis of Pseudomonas aeruginosa infectionsin cancer patients in the 1990s, EUR J CL M, 19(12), 2000, pp. 915-925
Authors:
Buchner, T
Hiddemann, W
Wormann, B
Loffler, H
Ludwig, WD
Schoch, C
Haferlach, T
Maschmeyer, G
Staib, P
Aul, C
Heyll, A
Gruneisen, A
Rasche, H
Eimermacher, H
Balleisen, L
Pielken, HJ
Reis, HE
Griesinger, F
Reichle, A
Sauerland, MC
Heinecke, A
Citation: T. Buchner et al., Acute myeloid leukemia in adults: Is postconsolidation maintenance therapynecessary?, INT J HEMAT, 72(3), 2000, pp. 285-289
Authors:
Gokbuget, N
Hoelzer, D
Arnold, R
Bohme, A
Bartram, CR
Freund, M
Ganser, A
Kneba, M
Langer, W
Lipp, T
Ludwig, WD
Maschmeyer, G
Rieder, H
Thiel, E
Weiss, A
Messerer, D
Citation: N. Gokbuget et al., Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL), HEMAT ONCOL, 14(6), 2000, pp. 1307
Authors:
Buchheidt, D
Hiddemann, W
Krcmery, V
Karthaus, M
Donnelly, JP
Wilhelm, M
Maschmeyer, G
Link, H
Adam, D
Helmerking, M
Citation: D. Buchheidt et al., European surveillance of infections and risk factors in cancer patients, EUR J CL M, 18(2), 1999, pp. 161-163
Authors:
Reinhardt, P
Maschmeyer, G
Schulze, G
Fleischer, C
Ellerbrok, H
Schlegelberger, B
Stein, H
Pauli, G
Ludwig, WD
Citation: P. Reinhardt et al., First non-imported HTLV-1 positive adult T cell leukemia/lymphoma (ATLL) in Germany, LEUKEMIA, 13(8), 1999, pp. 1296-1297
Authors:
Maschmeyer, G
Citation: G. Maschmeyer, Interventional antimicrobial therapy in febrile neutropenic patients, DIAG MICR I, 34(3), 1999, pp. 205-212
Authors:
Buchner, T
Wormann, B
Loffler, H
Gassmann, W
Haferlach, T
Fonatsch, C
Haase, D
Schoch, C
Hossfeld, D
Lengfelder, E
Aul, C
Heyll, A
Maschmeyer, G
Ludwig, WD
Sauerland, MC
Heinecke, A
Citation: T. Buchner et al., Double induction strategy for acute myeloid leukemia: The effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: A randomized trial by the German AML Cooperative Group, BLOOD, 93(12), 1999, pp. 4116-4124
Risultati:
1-13
|